The Ethical Implications of Cognitive Enhancers

Authors

  • Sydney Shearouse Department of Neuroscience
  • Shanaz Tejani-Butt Department of Neuroscience and Department of Pharmaceutical Sciences, University of the Sciences in Philadelphia, PA USA

Keywords:

cognitive enhancers, pharmacological, non-pharmacological, ethics

Abstract

This review will explore the ethical use of cognitive enhancers which alter and improve cognitive function and performance. Cognitive enhancers are not only used in the treatment of certain cognitive disorders, such as schizophrenia and attention deficit hyperactivity disorder (ADHD), but also by individuals to change or enhance certain cognitive abilities. The review will explore and understand the possible ethical implications of the availability of these enhancers to the general population.

References

. N Bostrom and A Sandberg. Cognitive Enhancement: Methods, Ethics, Regulatory Challenges. Science and Engineering Ethics, vol. 15, pp. 311-341, 2009.

. K Cherry. What is cognition? https://www.verywellmind.com/what-is-cognition-2794982 (Accessed April 27, 2021)

. BJ Sahakian and S Morein-Zamir. Neuroethical issues in cognitive enhancement. J Psychopharmacol., vol. 25, pp. 197-204, 2011.

. BJ Sahakian and S Morein-Zamir. Professor’s little helper. Nature, vol. 450, pp. 1157-1159, 2007.

. TW Weickert, TE Goldberg, JM Gold, LB Bigelow, MF Egan and DR Weinberger. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry, vol. 57, pp. 907-913, 2000.

. S Vaishnavi, K Gadde, S Alamy, W Zhang, K Connor and JRT Davidson. Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment. Journal of Clinical Psychopharmacology, vol. 26, pp. 373-378, 2006.

. JD Shearer, SC Rodgers, T Slade, I Van Beek, J Lewis, D Brady, R. McKetin, RP Mattick and A Wodak. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction, vol. 104, pp. 224–233, 2009.

. GH Kraft and J Bowen. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology, vol. 27, pp. 1995–1997, 2005.

. UA Zifko, M Rupp, S Schwarz, HT Zipko and EM Maida. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study. Journal of Neurology, vol. 249, pp. 983–987, 2002.

. AV Nieves and AE Lang AE. Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil. Clinical Neuropharmacology, vol. 25, pp. 111–114, 2002.

. M Dresler, A Sandberg, K Ohla, C Bublitz, C Trenado, AM Wasowicz, S Kuhn and D Repantis. (2013). Non-pharmacological cognitive enhancement. Neuropharmacology, vol. 64, pp. 529–543, 2013.

. M Husain and M Mehta. Cognitive enhancement by drugs in health and disease. Trends in Cognitive Science, vol.15, pp. 28-36, 2011.

. DC Turner, TW Robbins, L Clark, AR Aron, J Dowson and BJ Sahakian. Cognitive enhancement effects of modafinil in healthy volunteers. Psychopharmacology, vol. 165, pp. 260–269, 2003.

. TE Wilens. Attention deficit hyperactivity disorder and substance use disorders. American Journal of Psychiatry, vol.163, pp. 2059–2063, 2006.

. Office of Applied Studies. Results from the 2001 National Household Survey on Drug Abuse: I. Summary of National Findings. DHHS publication no. SMA 02–3758, NHSDA. Series H‐17, 2002. Rockville, MD: Substance Abuse and Mental Health Services Administration.

. LD Johnston, PM O'Malley, and JG Bachman. Monitoring the Future National Survey Results on Drug Use, 1975–2002: II. College Students and Adults Ages 19–40, 2003. NIH publication no. 03–5376. Washington, DC: US Department of Health and Human Services.

. CJ Teter, SE McCabe, CJ Boyd, and SK Guthrie. Illicit methylphenidate use in an undergraduate student sample: prevalence and risk factors. Pharmacotherapy, vol. 23, pp. 609–617, 2003.

. MS Stahl. Stahl's Essential Psychopharmacology: The Prescriber's Guide. Cambridge University Press, 2009.

. NICE. National Institute for Clinical Health and Excellence. (http://www.nice.org.uk/) Accessed November 2010.

. D Repantis, P Schlattmann, O Laisney, I Heuser. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacol Res., vol. 62, pp. 187-206, 2010.

. R Sequeira. Central nervous system stimulants and drugs that suppress appetite. Side Effects of Drugs Annual, Elsevier, vol. 32, pp.1-28, 2010.

. JK Aronson. Side Effects of Drugs Annual, Elsevier, vol. 32, pp.1-1004, 2010.

. A Roskies. Neuroethics for the new millenium. Neuron, vol. 35, pp. 21–23, 2002.

. N Levy. Neuroethics. WIREs Cogn Sci., vol. 3, pp. 143-151, 2012.

. E Racine. Enhancement of performance with neuropharmaceuticals: pragmatism and the culture wars. In: Racine E, ed. Pragmatic Neuroethics: Improving Treatment and Understanding of the Mind-Brain. Cambridge, MA: MIT Press; pp.121–138, 2011.

. DE Evans and DJ Drobes. Review: nicotine self-medication of cognitive-attentional processing. Addict Biol., vol.14, pp. 32–42, 2009.

. J Savulescu. Justice, fairness, and enhancement. Ann N Y Acad Sci., vol. 1093, pp. 321-338, 2006.

. B Weiss. Vulnerability of children and the developing brain to neurotoxic hazards. Environ Health Perspect., vol.108, pp. 375–381, 2000.

. D DeGrazia. Human Identity and Bioethics. Cambridge: Cambridge University Press, 2005.

. C Elliott. A Philosophical Disease: Bioethics, Culture and Identity. Psychology Press, 1999.

. D. Healy. Birth, Ritalin, Prozac, Viagra, Death. Bennett, Carney, Karpin (Eds.), Brave New World of Health, Federation Press, Sydney, 2008.

. A Sandberg and J Savulescu. The social and economic impacts of cognitive enhancements, in Enhancing Human Capacities, eds J. Savulescu, R. ter Meulen, and G. Kahane (Oxford: Wiley-Blackwell), pp. 93–112, 2011.

. C Chiamulera. Research is needed on the use of cognitive enhancer drugs in sport. Journal of Science and Medicine in Sport, vol.14, pp. 2-3, 2011.

. A Smith, C Brice, J Nash, N Rich and DJ Nutt. Caffeine and central noradrenaline: effects on mood, cognitive performance, eye movements and cardiovascular function. Journal of Psychopharmacology, vol.17, pp. 283-292, 2003.

. P Hewlett and A Smith. Effects of repeated doses of caffeine on performance and alertness: new data and secondary analyses. Human Psychopharmacology: Clinical and Experimental, vol. 22, pp. 339-350, 2007.

. LA Reyner and JA Horne. Suppression of sleepiness in drivers: combination of caffeine with a short nap. Psychophysiology, vol. 34, pp. 721-725, 1997.

. PB Dews, CP O'Brian and J Bergman. Caffeine: behavioral effects of withdrawal and related issues. Food and Chemical Toxicology, vol. 40, pp. 1257-1261, 2002.

. MI Posner, SE Petersen, PT Fox and ME Raichle. Localization of cognitive operations in the human brain. Science, vol. 240, pp. 1627-1631, 1988.

. D Benton and DS Owens. Blood glucose and human memory. Psychopharmacology, vol.113, pp. 83-88, 1993.

. D Benton, DS Owens and PY Parker. Blood glucose influences memory and attention in young adults. Neuropsychologia, vol. 32, pp. 595-607, 1994.

. AB Scholey, S Harper and DO Kennedy. Cognitive demand and blood glucose. Physiology and Behavior, vol. 73, pp. 585-592, 2001.

. C Messier. Glucose improvement of memory: a review. European Journal of Pharmacology, vol. 490, pp. 33-57, 2004.

. ME Smith and MJ Farah. Are prescription stimulants “smart pills”? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychological Bulletin, vol. 137, pp. 717-741, 2011.

. RH Burpee and W Stroll. Measuring reaction time of athletes. Research Quarterly, vol. 7, pp. 110-118, 1936.

. J Eriksson, G Kalpouzos, L Nyberg. Rewiring the brain with repeated retrieval: a parametric fMRI study of the testing effect. Neuroscience Letters, vol. 505, pp. 36-40, 2011.

. S Diekelmann and J Born. The memory function of sleep. Nature Reviews Neuroscience, vol. 11, pp. 114-126, 2010.

. A Lutz, HA Slagter, JD Dunne and RJ Davidson. Attention regulation and monitoring in meditation. Trends in Cognitive Sciences, vol.12, pp. 163-169, 2008.

. A Moore and P Malinowski. Meditation, mindfulness and cognitive flexibility. Consciousness and Cognition, vol.18, pp. 176-186, 2009.

. HS Hodgins and KC Adair. Attentional processes and meditation. Consciousness and Cognition, vol. 19, pp. 872-878, 2010.

. BK Holzel, U Ott, H Hempel, A Hackl, K Wolf, R Stark, and D Vaitl. Differential engagement of anterior cingulate and adjacent medial frontal cortex in adept meditators and non-meditators. Neuroscience Letters, vol. 421, pp. 16-21, 2007.

. KA Ericsson. Toward a science of exceptional achievement. Annals of the New York Academy of Sciences, vol.1172, pp. 199-217, 2009.

. AC Vink, MS Bruinsma and RJPM Scholten. Music therapy for people with dementia. Cochrane Database of Systematic Reviews. CD003477. DOI: 10.1002/14651858.CD003477.pub2. vol. 3, 2004.

. N Spiro. Music and dementia: Observing effects and searching for underlying theories. Aging Ment Health, vol.14, pp.891-899, 2010.

. N Talwar, MJ Crawford, A Maratos, U Nur, O McDermott and S Procter. Music therapy for in-patients with schizophrenia: exploratory randomised controlled trial. Br J Psychiatry, vol 189, pp. 405-409, 2006.

. N Suthana, Z Haneef, J Stern, R Mukamel, E Behnke and B Knowlton. Memory enhancement and deep-brain stimulation of the entorhinal area. New Eng. J Med., vol. 366, pp. 502-510, 2012.

. MA Nitsche, A Seeber, K Frommann, CC Klein, C Rochford, MS Nitsche, et al. Modulating parameters of excitability during and after transcranial direct current stimulation of the human motor cortex. The Journal of Physiology, vol. 568, pp. 291-303, 2005.

. J Reis, E Robertson, JW Krakauer, J Rothwell, L Marshall, C Gerloff, et al. Consensus: can tDCS and TMS enhance motor learning and memory formation? Brain Stimulation, vol.1, pp. 363-36, 2008.

. N Suthana, Z Haneef, J Stern, R Mukamel, E Behnke, B Knowlton, et al. Memory enhancement and deep-brain stimulation of the entorhinal area. New England Journal of Medicine, vol. 366, pp. 502-510, 2012.

. KB Clark, DK Naritoku, DC Smith, RA Browning and RA Jensen. Enhanced recognition memory following vagus nerve stimulation in human subjects. Nature Neuroscience, vol. 2, pp. 94-98, 1999.

. MB Iyer, U Mattu, J Grafman, M Lomarev, S Sato and EM Wassermann. Safety and cognitive effect of frontal DC brain polarization in healthy individuals. Neurology, vol. 64, pp. 872-875, 2005.

. B Dräger, C Breitenstein, U Helmke, S Kamping and S Knecht. Specific and nonspecific effects of transcranial magnetic stimulation on picture-word verification. European Journal of Neuroscience, vol.20, pp.1681-1687, 2004.

. F Mottaghy, M Hungs, M Brügmann, R Sparing, B Boroojerdi, H Foltys, et al. Facilitation of picture naming after repetitive transcranial magnetic stimulation. Neurology, vol. 53, pp. 1806-1812, 1999.

Downloads

Published

2021-05-08

How to Cite

Shearouse, S. ., & Tejani-Butt, S. . (2021). The Ethical Implications of Cognitive Enhancers. International Journal of Sciences: Basic and Applied Research (IJSBAR), 58(1), 54–63. Retrieved from https://www.gssrr.org/index.php/JournalOfBasicAndApplied/article/view/12380

Issue

Vol. 58 No. 1 (2021)

Section

Articles

License

Authors who submit papers with this journal agree to the following terms.